Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Safety and Efficacy Study Evaluating Glutamic Acid Decarboxylase Gene Transfer to Subthalamic Nuclei in Subjects With Advanced Parkinson's Disease

NCT00643890 is registered in ClinicalTrials.gov with Neurologix, Inc. as lead sponsor.

NCT NCT00643890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00643890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Safety and Efficacy Study Evaluating Glutamic Acid Decarboxylase Gene Transfer to Subthalamic Nuclei in Subjects With Advanced Parkinson's Disease
Lead sponsor
Neurologix, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2008
Completion date
Not reported
Enrollment
44 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease